WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...

Biotechnology leader Biocon is fully integrating Biocon Biologics, valuing it at $5.5 billion. The merger involves share ...

Trust is often a major barrier to companies integrating AI tools. Learn how better data governance can improve confidence.

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

Using biological agents as weapons is illegal, but an organism that scientists lawfully use for genuine research could be repurposed for an attack. Therefore, what is banned depends on what an actor ...

Indiana shows high potential for the state to become the premiere destination to research, commercialize, scale biotechnology ...

Cisgenics uses genes from closely related species that usually are sexually compatible. If governments choose to regulate it similarly to conventional breeding, experts say, it could herald a new ...

DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) saw its stock drop 11.5% on Tuesday after the company announced the ...

Medical and legal authorities spoke about the ethics and future of biotechnology at a Friday panel hosted by the Program on Science, Technology, and Society at the Harvard Kennedy School. As part of ...